Inventor · disambiguated record
Gerald W. Devries
Also filed as: DEVRIES GERALD W · DEVRIES GERALD WOODROW
15 granted patents·13 pending applications·53 citations·filing 2001–2022
91Inventor score
Top patents by PatentIndex Score
28 records- 0194US8968766B2Sustained release intraocular implants containing tyrosine kinase inhibitors and related methodsALLERGAN INC·Filed 2013·Granted Mar 3, 2015·19 cites·8 claims
- 0292US9233070B2Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2013·Granted Jan 12, 2016·6 cites·5 claims
- 0387US10076492B2Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2016·Granted Sep 18, 2018·4 cites·4 claims
- 0486US11078262B2High viscosity macromolecular compositions for treating ocular conditionsHUGHES PATRICK M·Filed 2007·Granted Aug 3, 2021·3 cites·14 claims
- 0585US10881608B2Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2018·Granted Jan 5, 2021·1 cites·7 claims
- 0683US11376252B2Multikinase inhibitors and uses in prostatic hyperplasia and urinary track diseasesAIVIVA BIOPHARMA INC·Filed 2017·Granted Jul 5, 2022·2 cites·11 claims
- 0783US8591885B2Carbonic anhydrase inhibitor sustained release intraocular drug delivery systemsCHANG JAMES N·Filed 2007·Granted Nov 26, 2013·6 cites·5 claims
- 0882US11278546B2Multikinase inhibitors and uses in ocular fibrosisAIVIVA BIOPHARMA INC·Filed 2017·Granted Mar 22, 2022·2 cites·18 claims
- 0981US7749530B2Kinase inhibitorsALLERGAN INC·Filed 2008·Granted Jul 6, 2010·5 cites·31 claims
- 1076US8455656B2Kinase inhibitorsSPADA LON T·Filed 2009·Granted Jun 4, 2013·2 cites·2 claims
- 1175US11400089B2Multikinase inhibitors and uses in reproductive and digestive tract fibrosisAIVIVA BIOPHARMA INC·Filed 2018·Granted Aug 2, 2022·2 cites·13 claims
- 1273US8143410B2Kinase inhibitorsSPADA LON T·Filed 2009·Granted Mar 27, 2012·1 cites·28 claims
- 1373US2010129435A1Methods and compositions for treatment of ocular neovascularization and neural injuryALLERGAN INC·Filed 2009·Application pending·0 cites
- 1473US2021121397A1Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2021·Application pending·0 cites
- 1569US2008176953A1Methods and compositions for treatment of ocular neovascularization and neural injuryALLERGAN INC·Filed 2007·Application pending·0 cites
- 1667US12138252B2Multikinase inhibitors of VEGF and TGF beta and uses thereofAIVIVA BIOPHARMA INC·Filed 2020·Granted Nov 12, 2024·0 cites·18 claims
- 1765US12502391B2Multi-kinase inhibitors of VEGF and TGF beta and uses thereofAIVIVA BIOPHARMA INC·Filed 2019·Granted Dec 23, 2025·0 cites·4 claims
- 1864US2022106388A1High viscosity macromolecular compositions for treating ocular conditionsALLERGAN INC·Filed 2021·Application pending·0 cites
- 1958US2003082183A1Methods and compositions for treatment of ocular neovascularization and neural injuryFiled 2002·Application pending·0 cites
- 2054US2022339148A1Multi-kinase inhibitors of vegf and tgf beta and uses thereofAIVIVA BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2153US8383825B2Kinase inhibitorsALLERGAN INC·Filed 2011·Granted Feb 26, 2013·0 cites·30 claims
- 2252US2012207810A1Kinase InhibitorsSPADA LON T·Filed 2012·Application pending·0 cites
- 2351US2013267497A1Kinase inhibitorsALLERGAN INC·Filed 2013·Application pending·0 cites
- 2450US2005281861A1Macromolecule-containing sustained release intraocular implants and related methodsALLERGAN INC·Filed 2005·Application pending·0 cites
- 2546US2006182783A1Sustained release intraocular drug delivery systemsALLERGAN INC·Filed 2006·Application pending·0 cites
- 2645US2019388407A1Multikinase inhibitors of vegf and tfg beta and uses thereofAIVIVA BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 2740US2003180294A1Methods of extending corneal graft survivalFiled 2002·Application pending·0 cites
- 2840US2002094998A1Methods and compositions for treatment of ocular neovascularization and neural injuryFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →